However, JQ1 alone was not enough to block tumor growth in a mouse model (Echevarría‐Vargas et al, 2018): As NRAS mutations cause multiple changes in intracellular signaling, targeting only one dysregulated signaling pathway may not be sufficient for lasting therapeutic effects. Here, NRAS is linked to neoplasm.